|
Abreast Of Ear, Nose &
Throat / Head & Neck Advances
26,March, 2006
|
|
Hello, All. Welcome
to this week's ORL Update. I do hope you
find the pick for this edition useful |
|
|
|
Biodun Olusesi,
Newsletter Editor |
Transcanal PGE1 and Increased CBF.......?
The cochlear blood flow (CBF) , which in human
is just about 0.0001% of the cardiac output, and
known to be influenced by several pharmacological
agents have been severally investigated for agents
ranging from steroids, adrenergic agonists,
adrenergic antagonists, vasodilators,
Leukotrienes, among others. Recall a previous
issue of the newsletter (Vol1No
5) where the paper reporting
topical application to round window (RW) of
rhodamine-encapsulated PLGA nanoparticles was
reviewed. Another study recently (Mitsuo
Tominaga et al,
Acta
Oto-Laryngologica, 2006; 126: 232 - 236)
investigated the effect of topical application of
PGE1 on CBF in experimental rats and guinea pigs
and observed increase in CBF in both animals, with
a presumption that if this result is validated in
subsequent studies, selective PGE1 to RW may
become useful in treatment of inner ear diseases.
Abstract:
Conclusions.
The increase in cochlear blood flow (CBF) after
administration of prostaglandin E1 (PGE1) to the
round window depends on increased blood flow
through the anterior inferior cerebellar artery
(AICA).
Objectives. To
evaluate the response of CBF to PGE1 applied
topically to the round window, and to investigate
the origin of blood flow changes after this
topical application.
Material and methods.
The response of CBF to topically applied PGE1 was
measured by placing the tip of a laser Doppler
probe on the bony wall of the basal turn of the
cochlea after the middle ear mucosa over the
cochlea had been removed in guinea pigs and rats.
In rats, the CBF response to PGE1 administration
was investigated after occlusion of the AICA or
stapedial artery.
Results.
CBF increased following PGE1 administration in
both guinea pigs and rats. In rats, CBF increased
from 100% to 132%9/10%
(mean9/SD)
after the topical application of 0.5
ml
of a 0.014% PGE1 solution. CBF decreased after
occlusion of the AICA or stapedial artery but did
not increase after PGE1 administration during
occlusion of the AICA. The CBF response to PGE1
administration was similar before and after
occlusion of the stapedial artery.
| |
|
|
TOP PICKS
PCA
Defect and Sudden Deafness..?
A recent open access study (Tsushima, Taketomi-Takahashi
& Endo,
BMC Ear, Nose and Throat
Disorders 2006,
6:5) designed to investigate the link
between sudden deafness and defect of posterior
communicating artery (PCA) failed to observe
statistically significant link between the two.
Abstract:
Background A strong association was
suggested between a non-functioning posterior
communicating artery (Pcom) of the circle of Willis and
sudden deafness (SD). The purpose of this study was to
determine the rate of depiction of the posterior
communicating artery (Pcom) on magnetic resonance
angiography (MRA) in patients with SD.
Methods Sixteen patients with SD (47.7 +/-
13.3 years; range, 24 - 76 years; nine males) were
evaluated with intracranial MRA as well as magnetic
resonance imaging (MRI) of the head. The depiction of
Pcom on MRA was correlated with the laterality of SD.
One hundred twenty-eight controls (49.1 +/- 8.4 years;
range, 22 - 66 years; 87 male) were selected from
neurologically normal subjects who underwent MR
examinations as a part of an annual medical check-up in
our hospital.
Results Four (25%) of 16 SD patients had
bilateral Pcom on MRA, four patients had unilateral Pcom
and eight patients had bilaterally absent Pcom These
results were not significantly different from the
controls (p=0.96). In 6 (37.5 %) of 16 SD patients, the
ipsilateral Pcom was present on MRA, and 104 (40.6%) of
256 Pcom were present in 128 normal controls (p=0.81).
Conclusions Since there was no link
between the occurrence of SD and the absence of the
ipsilateral Pcom, our results cannot support the
hypothesis that the absence of Pcom may be a risk factor
for the occurrence of SD.
Coming Events of Importance to Otolaryngologists in
Africa...
-
8th International Otology Course of the Jean Causse
Ear Clinic
June 22-24, 2006; Béziers, France
-
110th American Academy of ORL,Head & Neck Surgery
Annual Meeting & OTO EXPO
September 17-20, 2006;
Toronto, Canada.
-
42nd South African ENT Congress joint meeting with
the British Association of Otolaryngology - Head &
Neck Surgery
October 29-November 1, 2006;
Cape Town, South Africa.
For more Worldwide otolaryngological events and conferences....Click
Here
Dextran 40 & SD in Pregnancy....?
The recognized risks of
iv Dextran therapy (coagulopathy, renal failure and non-cardiogenic
pulmonary oedema) as well as the known riskt of
steroid therapy on the pregnant female as well as the
fetus puts the otolaryngologist at a crossroad when
faced with management of sudden deafness (SD) in
pregnancy. A new study from Taiwan (Yen-Ping Wang &
Yi-Ho Young,
Acta Oto-Laryngologica, 2006;
126: 271 -276) reported significant benefit
of Dextran 40 in pregnant women with SD without adverse
effect of the mother or fetus
Abstract:
Conclusion. Excluding the possibility of acoustic
neuroma, therapeutic benefits from dextran 40 can be
anticipated in a pregnant woman with sudden deafness,
leading to significant hearing improvement, without
detrimental effect on the mother or fetus. Objective.
The aim of this study was to present our experience in
the treatment of pregnant women with sudden deafness
during the past decade. Methods. From January
1994 to December 2003, 12 pregnant women with sudden
deafness were consecutively encountered at the authors’
clinic. With the exception of one patient with acoustic
neuroma who underwent craniotomy, six patients were
treated with dextran 40 only, while the other five
patients preferred no medication, and served as a
control group. Each patient underwent audiometry before
treatment and at 1 year postpartum. Results. In
the dextran group, five (83%) of six patients had
hearing improvement 1 year postpartum, compared with one
(20%) of five patients in the control group showing
hearing improvement; both groups revealed a significant
difference. Those receiving intravenous dextran
treatment had significant hearing improvement at the
frequencies of 1000, 2000, and 4000 Hz, at 1 year
postpartum. In contrast, in those who followed a natural
course without medication no significant difference
existed in the mean hearing level of each frequency, at
1 year after delivery.

|
|
|
|
|
|
CLINICAL RADIOGRAPH OF THE
WEEK |
A
55-year old male presented with reccurent
excruciating right hemicranial headache worse in
the right periorbital region of 4 months duration. The
onset was preceded by an attack of flu. There was
little response to analgesia.
Clinical and opthalmological examinations were
negative.MRI brain was negative. CT Scan of
sinuses revealed the feature shown (red outline).
You may want to
see other views
for clarity..
|
| |
|
|
What is the diagnosis?
- Parting Shot...
If you have an interesting
case to discuss or share with other Otolaryngologists
all over Africa, feel free to email
Me or at best go to
otolaryngology in Africa blogsite
and post your case
- Also, if you are among those who requested for a copy
of DODA at the last ORLSON Meeting @ Port Harcourt,
please take time to view the
DODA - FAQ page,
you should have received your copy by now. If you have
difficulty on using the program, please text
+2348032472069.
- An online video demonstration of doda is available
at
http://www.otolaryngologyinafrica.net/doda_video.htm
This
video takes about 30 - 45 minutes to fully load on a
broad band network the first time, but once fully
loaded could be viewed over and over again
- If you have anything you want to communicate with
other Otolaryngologists - news, request, etc, feel
free to email your communication to
orl-mailer@
otolaryngologyinafrica.net.
Your request will appear in member's page soon to be
created.
- Reviewers wanted for otolaryngology news journals
watch page. If you are an Otolaryngologist in Africa
and will like to be our journal reviewer, please feel
free to email
orl-mailer@otolaryngologyinafrica.net
- DODA 2006, capable of advanced hearing measure,
and also paediatric hearing assessment is being
developed. If you requested for and got a free copy of
DODA, you may also look out for this latest version
dubbed DODA 2006, as well as for an additional page on
outcome of hearing assessment using DODA.
- Watch out for otolaryngological.net Journal Club
Page!
Till Next Week,
Biodun
|
|
|
|
This is a free email newsletter
circulating to Otolaryngologists in Africa, and interested
Otolaryngologists elsewhere. If you know anyone interested
in receiving this free newsletter, feel free to forward a
copy to such person or encourage them to email
orl-mailer@otolaryngologyinafrica.net for
subscription
© Copyright Dr 'Biodun
Olusesi,
2005 - 2006 |